The diagnostics portfolio was expanded with ... Some of its current pipeline highlights include: Abbott Laboratories began its 125th year with approximately $22 billion in revenues and ...
Diversified Product Portfolio: Abbott Laboratories' diverse range of medical devices, diagnostic testing products, nutritional products, and branded generic pharmaceuticals is a significant strength.
Becton Dickinson surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its drug-delivery devices. Becton Dickinson beats quarterly estimates on ...
As Abbott Laboratories prepares to build a plant and bring 450 jobs to Bowling Green, company officials asked for permission to have more fencing and less greenery than required by city zoning. On ...
Unfortunately for shareholders, while the Abbott Laboratories (NYSE:ABT) share price is up 38% in the last five years, that's less than the market return. Zooming in, the stock is up a respectable ...